NeuroOne Medical Technologies Corp (NAS:NMTC)
$ 1.06 -0.03 (-2.75%) Market Cap: 29.17 Mil Enterprise Value: 26.85 Mil PE Ratio: 0 PB Ratio: 7.26 GF Score: 49/100

Q2 2022 Neuroone Medical Technologies Corp Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: $0.5394 (+1.75%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the NeuroOne Medical Technologies Corporation second-quarter of fiscal 2022 earnings conference call. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and its Chief Financial Officer, Ron McClurg.

Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements within the meaning of US Federal Security laws with respect to future operations, financial results, events, trends, and performance, which are based on management's beliefs and assumption as of today's call or other specified dates.

Forward-looking statements may involve known and unknown risks, uncertainties and other factors which may cause actual results to differ materially from those expressed or implied by such statements. See our earnings release and SEC filings for information regarding specific risks and uncertainties that could cause actual results to differ. Except as required by law, we undertake no obligation to update such forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot